Aptus Pharma IPO is to open on September 23, 2025. It is a SME IPO that will raise ₹13.02 crores. The Aptus Pharma IPO price band is fixed at ₹65 to ₹70 with a market lot of 4,000 Shares.
Aptus Pharma IPO GMP Live Rates day by day with Kostak rates.
| Date | IPO GMP | GMP Trend | Gain |
| 30 Sep | ₹4 |  | 5.71% |
| 29 Sep | ₹4 | | 5.71% |
| 27 Sep | ₹4 | | 5.71% |
| 26 Sep | ₹4 | | 5.71% |
| 25 Sep | ₹8 |  | 11.42% |
| 24 Sep | ₹7 | | 10% |
| 23 Sep | ₹7 | | 10% |
| 22 Sep | ₹7 | | 10% |
| 20 Sep | ₹- | – | -% |
Aptus Pharma IPO Details
| IPO Open Date | September 23, 2025 |
| IPO Close Date | September 25, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹65 to ₹70 Per Share |
| Issue Size | Approx ₹13.02 Crores |
| Fresh Issue | Approx ₹13.02 Crores |
| Issue Type | Book Built Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Aptus Pharma IPO Dates
| IPO Open Date: | September 23, 2025 |
| IPO Close Date: | September 25, 2025 |
| Basis of Allotment: | September 26, 2025 |
| Refunds: | September 29, 2025 |
| Credit to Demat Account: | September 29, 2025 |
| IPO Listing Date: | September 30, 2025 |
| IPO Bidding Cut-off Time: | September 25, 2025 – 5 PM |
Business Overview
Aptus Pharma is one of the leading companies in terms of marketing and selling pharmaceutical products. This firm does not have its own factories but gets the products made through contract manufacturers.
The company provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. The company works with many healthcare professionals in different areas, including general doctors, child specialists, women’s health doctors, heart specialists, diabetes doctors, brain specialists, and others.
The company has various promoters, wherein Mr. Tejash Maheshchandra Hathi has more than 20 years of experience in the pharmaceutical industry.
Aptus Pharma IPO GMP aka Grey Market Premium FAQs:
What is Aptus Pharma IPO GMP Today?
What is Aptus Pharma IPO Expected Returns?
Disclaimer:
- IPO Grey Market Premium (Aptus Pharma IPO GMP) mention is valid for the specific date as mentioned in the header.
- We are not buying and selling IPO forms on IPO Grey Market.
- Kostak Rate is the premium one gets by selling his/her IPO application (in an off-market transaction) to someone else even before allotment or listing of the issue.
- Do not subscribe for IPO by just seeing the premium Price as it may change anytime before listing. Subscribe only considering the fundamentals of the companies.
